Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
[99mTc]Tc-L2-PDA
- Development stage
- Unknown
- Lead developer
- Beijing Normal University
- Modality
- Gamma Emitters → Radiopharmaceuticals
01
Overview
[99mTc]Tc-L2-PDA: sourced facts only. name: "Among them, [99mTc]Tc-L2-TPPTS and [99mTc]Tc-L2-PDA showed superior cellular uptake and specific binding to FAP." [PMID:39908795]; target: "Among them, [99mTc]Tc-L2-TPPTS and [99mTc]Tc-L2-PDA showed superior cellular uptake and specific binding to FAP." [PMID:39908795]; developer: "Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Normal University, Beijing, 100875, PR China; Key Laboratory of Beam Technology of the Ministry of Education, School of Physics and Astronomy, Beijing Normal University, Beijing, 100875, PR China." [PMID:39908795]
Beyond the preview
Go deeper on [99mTc]Tc-L2-PDA.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on [99mTc]Tc-L2-PDA.